Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection
Background: Lassa virus (LASV) can cause severe acute systemic infection in humans. No approved antiviral drugs or vaccines are currently available. Antibody-based therapeutics are considered a promising treatment strategy in the management of LASV disease. Methods: We used chimeric Ifnar?/? C57B...
Gardado en:
Autoren: | , , , |
---|---|
Formato: | Artigo |
Idioma: | inglés |
Publicado: |
Philipps-Universität Marburg
2023
|
Schlagworte: | |
Acceso en liña: | Texto completo PDF |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
Internet
Texto completo PDFNúmero de Clasificación: |
urn:nbn:de:hebis:04-es2024-04459 |
---|---|
Data de Publicación: |
2024-01-18 |
Fonte: |
Erstveröffentlichung: Oestereich, L.; Müller-Kräuter, H.; Pallasch, E.; Strecker, T. Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection. Viruses 2023, 15, 1436. https://doi.org/10.3390/v15071436 |
Downloads: |
19 (2024) |
Lizenz: |
https://creativecommons.org/licenses/by/4.0 |
URL de acceso: |
https://archiv.ub.uni-marburg.de/es/2024/0445 https://doi.org/10.3390/v15071436 |